News of Interest
AMLI Annual Meeting 2017
EUROIMMUN US, Inc., a subsidiary of EUROIMMUN, is a world leader in the field of medical diagnostics. EUROIMMUN established itself as an industry innovator with its unique IFA BIOCHIP Mosaic technology and has successfully introduced new technologies such as ELISA, Western & Immunoblot assays since its inception in 1987. The company’s global success is attributed to its strategic product development in which designer antigens, as well as patented and licensed technologies, play an important role. EUROIMMUN is consistently expanding its product offerings with new assays to aid in the detection of antibodies associated with autoimmune diseases, infectious diseases, and allergy.
EUROIMMUN is dedicated to delivering the highest quality products matched with unsurpassed scientific and technical support. EUROIMMUN is an FDA registered facility and is ISO 9000 certified. EUROIMMUN US, Inc. has obtained a significant number of product clearances from the FDA with the majority of products also carrying CE marking.
Now and in the Future
Our areas of expertise are supported by a strong scientific team committed to improving healthcare by delivering innovative, clinically relevant diagnostic assays that aid in the diagnosis of autoimmune and infectious diseases. Worldwide, EUROIMMUN offers one of the most extensive test menus in a variety of technology platforms: IFA BIOCHIP Mosaics, ELISA, Immuno/Western blot, EUROLine, EUROArray, and EUROPattern/IFA automation.